Riska M, Haryati H, Suhartono E, Wanahari TA. Prognostic Value of the Systemic Immune-Inflammation Index in EGFR Mutation-Positive Lung Adenocarcinoma Patients Treated with Tyrosine Kinase Inhibitors. JR [Internet]. 2022 Sep. 30 [cited 2024 Nov. 5];8(3):133-9. Available from: https://e-journal.unair.ac.id/JR/article/view/36027